Biological and Biosimilars Drug Market in Poland 2013

Publisher Name :
Date: 31-Aug-2013
No. of pages: 120
Inquire Before Buying

Examine the future of biologics in the Polish pharma market.

Report surveys biologic and biosimilar drugs, epidemiology and growth potential 2013- 2015.

In Poland, as in many parts of the world, a growing number of patients are being treated using biological or biosimilar drugs. The list of illnesses for which these drugs are prescribed includes psoriasis, Crohn's disease, colitis, psoriatic and rheumatoid arthritis, ankylosing spondylitis and others. Consequently, the market has expanded recently to encompass new drugs and therapies designed to treat a growing variety of conditions and illnesses.

Biologic and biosimilars drug market in Poland 2013, Development forecasts for 2013-2015 is a new PMR report designed to evaluate current market conditions and investigate the possibilities for growth and expansion in the coming years. From market size to research and development efforts of leading companies, this publication offers expert analysis of this market.

This document analyses the epidemiology fueling the growth of biologics in Poland, revealing the number of patients receiving these drugs. It analyses the reasons behind expansion and the potential obstacles that exist or will appear by 2015.

The competitive atmosphere of this segment of Poland's pharmaceuticals market is carefully evaluated using profiles of the major Polish manufacturing companies active in this market that include financial condition updates, plans for upcoming additions to their product lines and plans to engage in new research and development activities. Recent entries into the Polish biologics market are examined along with the likelihood of M&A and consolidation activity in the next two years.

The expiration of various patents for biologic drugs is a timely market topic, and this publication highlights the businesses ready to capitalise on new developments. It reviews the mechanics of the market, offering explanation of the registration and refund procedures that apply to biologics in Poland and covering recent and upcoming regulatory changes and their likely impact on businesses supplying this market.

Biologic and biosimilars drug market in Poland 2013, Development forecasts for 2013-2015 is a long-awaited business information tool that will aid companies involved in the manufacturing and distribution of these drugs within the Polish market and especially those which want to enter this young market. Related companies engaged in ingredient manufacturing and drug research will also find this report vital to new drug development, keeping up with legal requirements for business operation in this segment and preparing corporate reports and forecasts for internal use. Users of this publication come from pharmaceutical companies, consulting and research services providers and government agencies, financial institutions and chambers of commerce.

Biological and Biosimilars Drug Market in Poland 2013

Table Of Contents

I. Methodology 9

II. Executive summary 15

III. Market overview 19

IV. Results of the survey conducted among 35 companies operating on the market of biologicals and biosimilars in Poland 37

V. Biologicals in treatment of selected diseases in Poland 49

VI. Profiles of selected companies operating in the sector in Poland 97

VII. List of graphs 113

VIII. List of tables 117

IX. About PMR 119

  • Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2016
    Published: 01-Nov-2016        Price: US 1450 Onwards        Pages: 79
    DelveInsight's, "Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2016" discusses the global insulin biosimilar industry. Report analyzes that Insulin and Insulin Biosimilars holds a future Scope and potential in the market. It highlights the market trends, regulatory requirements for US and EU and key domestic players. Report provides an insight on Insulin Biosimilars that are under development for Type 1 and Type 2 Diabetes with an in......
  • China Biologics and Biosimilars Market Research Report 2016
    Published: 26-Oct-2016        Price: US 3200 Onwards        Pages: 123
    Notes: Sales, means the sales volume of Biologics and Biosimilars Revenue, means the sales value of Biologics and Biosimilars This report studies Biologics and Biosimilars in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Pfizer - Roche - Amgen - AbbVie - Sanofi - Johnson & Johnson - Novo Nordisk - Novartis......
  • China Biosimilars Market Research Report 2016
    Published: 25-Oct-2016        Price: US 3200 Onwards        Pages: 117
    Notes: Sales, means the sales volume of Laser Capture Microdissection Revenue, means the sales value of Laser Capture Microdissection This report studies Biosimilars in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Sandoz International GmbH (Germany) - Hospira, Inc. (U.S.) - Teva Pharmaceutical Industries Ltd. (Israel) - Dr. Reddy's Lab......
  • China Biosimilar Drug Market by Manufacturers, Type and Application, Forecast to 2021
    Published: 04-Oct-2016        Price: US 4480 Onwards        Pages: 101
    Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biosimilar Drug in China market. This repo......
  • Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis
    Published: 03-Oct-2016        Price: US 1350 Onwards        Pages: 177
    The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020.  With the continuous increasing demand for biologics, manufacturers are looking for novel strategies that will help them attain maximum returns on investment. Biosimilars are seen as the key weapon to curbing soar......
  • Global mAb Biosimilars Market 2016-2020
    Published: 23-Sep-2016        Price: US 2500 Onwards        Pages: 103
    Biosimilars or follow-on biologics are generic versions of the biopharmaceutical products. These are developed following the patent expiry of an original molecule. Biosimilars have the same biological properties as original drugs and target the same diseases. They have many similarities but are not identical to the reference biopharmaceutical product. The analysts forecast spending on the global monoclonal antibody (mAb) biosimilars market to grow at a CAGR of more than 57% durin......
  • Global Biologics and Biosimilars Market Professional Survey Report 2016
    Published: 08-Aug-2016        Price: US 3500 Onwards        Pages: 110
    Notes: Production, means the output of Biologics and Biosimilars Revenue, means the sales value of Biologics and Biosimilars This report studies Biologics and Biosimilars in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production......
  • United States Adalimumab Biosimilar Industry 2016 Market Research Report
    Published: 02-Aug-2016        Price: US 3800 Onwards        Pages: 130
    The United States Adalimumab Biosimilar Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Adalimumab Biosimilar industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Adalimumab Biosimilar market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development s......
  • Global Biosimilars Market 2016-2020
    Published: 01-Aug-2016        Price: US 2500 Onwards        Pages: 152
    Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator's product. They have many similarities, but are not identical to, the reference biopharmaceutical product. The analyst forecast global biosimilars market to grow at a CAGR of 5......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs